Introduction
Virally driven tumour cytotoxicity is an expanding field in antitumoral research. [1] [2] [3] [4] [5] [6] Technically, it relies on two exclusive modus operandi, tumour-restricted cytolytic replicative viruses or suicidal recombinant viral vectors. Whereas several viral genera have been employed for both approaches, only adenovirus based agents are currently in the clinic. 7, 8 Among the viral vectors, those derived from alphaviruses occupy a specialized niche. 9, 10 Semliki Forest Virus (SFV) and Sindbis Virus (SV) are the main two alphaviruses from which vectors have been obtained. 11, 12 In agreement with their biology, these vectors are predominantly adapted to high levels of transient transgene expression. This results from an optimized cytoplasmic genomic replication combined with the cytotoxic effect induced by a number of virally encoded proteins. 9 The clinical applications of SFV-derived vectors are therefore restrained to situations where such a pattern of expression appears suitable, namely, geneticbased vaccination and the eradication of an invasive cell proliferation, as observed in cancer. Moreover, recent experimental reports showed that alphavirus-derived vectors harbour an unexpected specificity to replication in tumour cells. [13] [14] [15] Nevertheless, numerous features of SFV biology remain open to clarification. This knowledge might lead to technological improvements and extend the use of SFV-derived vectors.
In order to develop better tools, two topics are the focus of ongoing studies, biosafety issues as well as the understanding of cancer cell replication specificities. It is noteworthy that vectors would take advantage of a precise and complete knowledge of the alphavirus cell cycle.
A companion paper by Lundstrom 10 gives a useful overview of the main steps of the alphavirus life cycle, introducing the essential features needed to understand alphavirus vectors. In addition, we will comment on the use of an unconventional trans-complementation approach for the production of SFV vectors. 16 We have recently described an efficient procedure for the mobilization of SFV replicons by the means of virus-like particles (VLP) (Figure 1 ). These particles are made of a membrane-anchored vesicular stomatitis virus glycoprotein (VSV-G) protein forming a lipo-protein shell encapsulating a full-length SFV replicon. 16 More recently we have shown that the biological behaviour of the VLP resembles that of viral particles in several ways, leading to cell entry (Diatta et al unpublished data). We also observed unexpected features that triggered a series of experiments dedicated to the understanding of the relationship established between the SFV replicon and its cellular environment.
As noticed in other viral taxa, such as retroviruses, viruses and cells have evolved several molecular mechanisms that rule their biological association. 17 In the present review, we will concentrate on alphavirus-derived vectors biology with a specific interest on cellular factors. Host gene products exert a dual effect; on the one hand, some proteins positively participate in viral replication and, conversely, when induced upon infection, other cellular products aim to hamper viral propagation. engineered to promote gene delivery and expression from various strains of alphavirus, including SFV. 18, 19 The most striking feature of an SFV-derived vector is its genetic structure, which allows the generation of a selfreplicating element, the replicon. A SFV replicon is composed of a single RNA that contains all the genetic information needed for self-amplification and transgene expression. There are two ways by which the replicon could be delivered to a target cell. 4, [20] [21] [22] The most common system is based on RNA or DNA transfection. For in vivo use, the formation of recombinant particles is possible through trans-complementation. However, in the case of recombinant particle formation, safety issues must be considered since recombination events are frequent and lead to fully replicative autonomous particles. 23 Genetic modification of the trans-complementation vectors has recently improved the safety of SFV vectors. 23 Considering the biosafety, the VLP offer a relevant alternative to recombinant SFV. One key advantage conferred by the VLP comes from the heterologous origin of the trans-complementing material. 16 Of note, in this approach, replicon packaging is not based on an interaction between the SFV capsid and a sequence contained within the nonstructural protein (nsP) 2 open reading frame of the full length SFV RNA. Thus, we had to find a substitutive method to achieve the exclusive packaging of a complete replicon. Indeed, Rolls et al 24, 25 showed that alike VLP were able to package genomic RNA as efficiently as sub-genomic. The subgenomic RNAs that don't have auto-replicative capabilities are not suitable for gene transfer approaches. Therefore, we have introduced several mutations into the internal 26S promoter. In the absence of sub-genomic RNA synthesis, we obtained an exclusive packaging of the fully autonomous genomic RNA. To obtain successful transgene expression, it was hence necessary to use an internal translation initiation, which can efficiently be obtained by using a picorna virus internal ribosome entry sequence (IRES). 26 
Molecular events along the process of cell transduction
We will now concentrate on the cellular events observed when using recombinant SFV particles or VLP (Figure 2 ). To get efficient transgene delivery, recombinant viral vectors must preserve some features of the regular viral cycle while eliminating others. The most striking difference between nonreplicating viral vectors and the wild type parental virus, resides in the late events governing particle formation, which are nondesirable most of the time and are therefore hampered in the case of vectors. Conversely, early events that allow efficient transgene delivery must be indistinguishable in the two species. It is noteworthy that each step of the viral cycle is susceptible to target-cell-specific modulation.
Entry
Classically, the sequential events leading to delivery of the viral genomic material are divided into entry, including decapsidation, which is followed by the cytoplasmic addressing of the viral genome. 27 At the end of the latter process, the viral genome is addressed to the cellular compartment where it will ultimately replicate and drive expression of the viral gene products. Efficient, virally promoted, cellular entry is the raison d'être for the use of recombinant viruses in gene transfer. All viruses, including alphaviruses, enter a target cell using a defined pathway that involves a virally encoded protein expressed at the particle surface and a cellular receptor at the plasma membrane. 27 First, we shall consider the envelope protein density at the particle surface, together with the receptor exposed at the cell surface. For retroviruses, these two features are known to directly influence entry. [28] [29] [30] In the case of SFV vectors, the high amount of envelope proteins generated through sub genomic translation appears to prevent a deficient envelope filling of the particles. Conversely, receptor based restriction has been described for SFV. 31 While the precise receptor for SFV is still unknown, it is acknowledged to be widely expressed. 32 Therefore, cells resistant to transduction might express the protein but fail to make it available. In some circumstances, this defect in receptor accessibility could be circumvented by the use of nonspecific chemical agents that promote enveloped virus-cellular membrane interaction. 31 Moreover, as for other enveloped virus pseudotyping, a simple procedure that allows receptor shift can provide a means to strengthen vector-cell affinity. [33] [34] [35] For SFV vectors, the VSV-G VLP achieves some kind of pseudotyping, leading to a broad entry tropism. 16, 24, 25, 36 Of note, other procedures involving the formation of heterologous particles are possible to expose various envelopes at Figure 1 Representation of the different steps in VLP production process. At day 1, the transcomplementing, envelope expressing plasmid is transfected; followed, at day 2, by a DNA form of the replicon. Viral harvest is performed at day 3. CMV: immediate-early cytomegalovirus promoter. VSV-G: vesicular stomatitis virus glycoprotein. NsP: nonstructural proteins. R.S: retroviral sequence. IRES: internal ribosome entry site. EGFP: enhanced GFP.
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E Piver et al the surface of SFV replicon containing particles (E Piver and JC Pagès unpublished data). Following receptor-envelope interaction, the complex has several possible routes to deliver the viral genomic material within the target cell. For these postbinding events, it is common to distinguish a pH-dependent and a pH-independent pathway. 27, 37 The latter process allows a direct fusion at the cell surface, while the former involves an endosome-mediated internalization. SFV is a prototypic virus for endosome-dependent entry and this is also the case for the derived vector particles. Upon acidification, a conformational envelope change promotes an endosome disruption and viral delivery. Of note, the membrane cholesterol content appears to influence the efficacy of SFV entry. [38] [39] [40] Concerning the VSV-G VLP, we have shown that entry promoted by the VSV-G was also dependent on pH lowering, as for the parental virus. Moreover, nystatin C, a cholesterolsequestering agent, has no obvious effect on VLP mediated replicon delivery (A Diatta unpublished 
. We have also shown a partial inhibition of transduction when the target cell was preincubated with brefeldine A, a compound that displays a pleiotropic action on the vesicular traffic within cells. 41 These data confirm the early endosome-mediated mode of entry of the VLP and suggest that the reduction, in replicon expression observed using brefeldin A might result from impairment in cytoplasmic vacuole (CPV) formation.
Following entry, cytoplasmic SFV replicons are associated with membrane structure, plasma membrane as well as endosomal and CPV derivative. 42 These cellular structures are formed from endosomes and lysosomes 3 h after an SFV infection, and appear crucial for plus strand RNA synthesis. 43 The nsP 1 has an essential role in determining membrane association (Figure 3) . [42] [43] [44] This protein contains two membrane-targeting signals, a stretch of 19 charged and hydrophobic amino acids interacting with phospholipids, and three palmitoylated cysteins. It is noteworthy that the membrane association of nsP 1 regulates the enzymatic activity of the protein. 43 Whereas nsP 1 missing the palmitoylation signal is still weakly associated with the plasma membrane, replicons harbouring this mutation are severely impaired in their replication (E Piver unpublished data and A Merits personal communication). Therefore, membrane targeting might be essential to SFV replication.
Innate immunity and virally induced cytotoxicity
Cells have evolved a series of molecular mechanisms devoted to the elimination of foreign intruding pathogens. 45 According to the wide diversity of pathogenic agents, the innate cellular defence response is triggered by nucleic acids, lipo-polysaccharide or proteinaceous material. The two most studied systems include the IFNinduced response and the Toll-like receptor-driven (TLR) molecular cascade. 46, 47 Of note, these two pathways are overlapping, the TLR pathway being able to trigger IFN (a/b) synthesis. The molecular effectors involved in IFN and TLR response are broadly distributed throughout cell types, despite some specificity. Of the two classes of IFN, only IFN I is active on most cell types, IFN g essentially being restricted to antigen-presenting cells and NK. In the perspective of vector use in vaccination and cancer therapy, we need to understand the different cellular modifications induced by these molecules upon replicon expression. Anticancer or immune responses are expected to be maximal if the transduced cells express the replicon at high levels. Therefore, we have to avoid delivery of the vector into a cell type where replication, and therefore cytotoxicity, is severely hampered by the innate response. Conversely, during the vector-producing step, we would like to take advantage of a comprehensive modulation of the replicon-induced cytotoxicity to obtain high recombinant titre. This is specifically the case when using the VSV-G VLP, where the VSV-G is produced by the RNA Pol II-dependent cellular machinery. 11, 16 Any reduction in the transexpression of the VSV-G directly affects the titre and thereby the utilization opportunities of the produced particles.
We shall now consider the proteins involved in the two pathways. The double-stranded RNA-dependent protein kinase (PKR) is controlled by the IFN I family of proteins. In SFV biology, PKR protein has proved to be involved in the downregulation of cellular mRNA translation. The PKR harbours an autocatalytic kinase activity that converts an inactive monomeric enzyme into a fully active dimeric phosphorylated enzyme that will phosphorylate various cellular factors. The presence of cytoplasmic ds RNA acts as an essential co-factor that controls the activity status of the PKR. When activated, the PKR phosphorylates several targets including the elongation factor 2 a (elF2a) at position 51. 48, 49 Upon phosphorylation, elF2a is inactivated and therefore induces a broad translation inhibition. During vector production, it might therefore be suitable to control this response. The use of a negative transdominant mutant of PKR has been exploited to modulate SFV cytotoxicity. Alternatively, cells expressing a mutated phosphorylation defective elF2a could be advantageous. Nevertheless, a recent report indicated that not all the protein synthesis shutoff is explained by the PKR activation. 50 Other inhibiting pathways remain to be characterized. Among the IFN I responsive genes, the MxA gene product has been shown to inhibit SFV replication through protein-protein interaction. 51 While it is obvious that the cellular localization of SFV/MxA interaction is cytoplasmic, the precise molecular mechanisms explaining the inhibition is presently not clear. It is noteworthy that using a transdominant negative mutant of the MxA protein, we have not been able to significantly improve SFV vector expression (A Diatta and JC Pagès unpublished data). The last IFN I-dependent factor that could negatively influence SFV replicon function is the RNase L, which is involved in 
Cellular factors and SFV vectors
E Piver et al mRNA and rRNA hydrolysis. 52 Interestingly, several viruses have selected a series of proteins in order to neutralize each of these factors. It could be worth envisioning the use of such proteins to increase SFVderived vector titre in producing cells.
The TLR family of proteins has a central role in innate immunity and contains 10 members. 47, 53 The system functions at different cellular levels crucial for virus entry, by using compartmentalized receptors sensitive to a specific type of agent. Despite this diversity of sensors, the transduction pathways activated upon TLR binding are convergent and share several of the proteins transducing the information. While several TLR have been reported to respond to either ss or ds RNA, to date, SFV replication appears not to switch on a TLR pathway. This is surprising since the TLR 3 recognizes ds RNA, which is actively produced in SFV infected cells. However, other viruses with ds RNA intermediate proved to replicate with the same efficiency in TLR3 +/+ or TLR3 À/À mice. 54 One explanation for this observation could be that the viral mode of entry employed by SFV does not allow TLR3 activation, despite the fact that TLR3 is found within the endocytic compartment.
Recently, ZAP, a zinc-finger protein has been shown to modulate infection of retroviruses by interacting with their transcription products. 17, 55, 56 Furthermore, this protein also proved to exert a potent inhibitory effect on alphaviruses. Considering the exclusive cytoplasmic life cycle of the SFV, the nuclear-cytoplasm shuttling of ZAP might explain this observation. 57 Now, bearing in mind the dramatic effect of ZAP on alphavirus replication, the protein is certainly absent within the cells classically used to produce SFV recombinant particles. ZAP might therefore have a negative role only in target cells. Together with its mode of action, it will be interesting to unravel the factors controlling ZAP expression.
Apoptosis, programmed cell death, is a common event induced by several cytolytic viruses. Likewise, alphavirus-infected cells have been shown to undergo apoptosis. 58 Among viral proteins, nsP 2, which contains a nuclear localization signal, is thought to actively participate in the apoptosis of replicon-expressing cells. 13, 59, 60 This is, at least partially, confirmed by the study of naturally arising variants, which show a milder phenotype when injected into mice. Upon sequence analysis, the largest part of these mutants proved to harbour nsP 2 modifications. 58 Similarly, Perri et al 61 have described a procedure for the in vitro selection of replicons with no cytotoxicity. Whereas single mutations have been unsuccessful in giving rise to long-term in vivo expression, a combination of mutations has allowed the generation of a long-lasting replicon. 20, 62 It is noteworthy that the variants show a cell type-dependent phenotype and that the level of transgene expression is lower than that of wild-type replicons. 16 Furthermore, such inferior replication could be detrimental to the recombinant vector production process using the VSV-G. Finally, as for innate immunity, the development of an apoptosis-free replicon is of limited interest for the main SFV vector applications, cancer therapy and vaccination. The use of exogenous apoptosis regulators seems more relevant, allowing a transient control of cell death only during the production steps.
Expression
Classically, transgene expression from SFV vectors is obtained using one or more internal 26S promoters. 10, 22 High levels of subgenomic RNA or transgene expression is achieved late in the infection cycle. At the time of transgene expression, most of the cellular functions are subject to virally induced extinction. Therefore, it has to be kept in mind that, if the transgene needs to be expressed together with a cellular cofactor, this product should probably be also vectorized to be in sufficient amount. Here, the use of poorly cytotoxic-derived vectors is advantageous. However, as mentioned above, the relevancy of attenuated SFV vectors is less evident.
An alternative to the use of an internal promoter is to clone the transgene 3 0 to an IRES. 16 An IRES offers the advantage of an expression arising earlier in the SFV life cycle. Nevertheless, an IRES needs certain cellular factors for optimal activity. 63 The lack of availability of these factors might lead to reduced transgene expression, as has been reported in HeLa cells. The length of the polyA tail also has an influence on gene expression. 64 More sophisticated systems of translational control are now available and could be beneficially exploited. 65 
Safety
Safety concerns arise when using recombinant SFV particles. This essentially results from the generation of autonomous particles at the stage of vector production. As SFV has been rarely implicated in severe infection in humans, any contamination must be prevented. Cytoplasmic RNA recombination leads to the reconstitution of complete viral genomes when producing recombinant particles using two complementary RNAs. If they exist, cellular determinants driving recombination are not yet identified. As BHK21 cells are the most widely used for vector production, no cell type differences have been reported concerning the likelihood of recombination. It is also possible that the recombination events arise through template switching promoted by the replicase, as this is the case for retroviruses. 66, 67 The use of split genomes, together with the introduction of conditional mutations into structural genes, has strongly reduced the likelihood of these recombination events. 23, 68 However, a risk still persists. The recent advent of an easy to handle system, dedicated to the control of translation, will certainly provide an excellent tool to reinforce the safety of recombinant viral-vector production. 65 For example, it could be worth introducing, within the trans-complementing constructs, a constitutive nsP shutdown RNA. Following transfection of the complementary plasmid, as in the standard procedure to generate recombinant particles, nsP translation inhibition would be relieved through drug addition. If an autonomous recombinant species is generated, it should always be silent in the absence of the defined drug. Moreover, to get rid of the silencing sequence, one supplementary recombination event is needed. The strategy therefore reduces the odds of autonomous particle formation.
Conclusion
In the case of persistent nonlytic viruses, sometimes leading to a state of latency, host/virus interactions are generally complex. The lentivirus HIV-1 is one of the Cellular factors and SFV vectors E Piver et al most studied models revealing continuous crosstalkbetween the virus and its host. Conversely, less is known about host factors that modulate the phenotype of cytopathogenic viruses. In the case of alphaviruses, there is no doubt that certain aspects of their life cycle are influenced by host factors. This is highlighted by the description of some cell specificity of cytotoxicity. A significant example for this comes from the unique profile of viral replication. Within mosquitoes, which are the first essential hosts for virus propagation, replication appears less deleterious than in rodents where replication leads to pathology. In addition, the spontaneous arising of nonpathogenic viral strains indicates that such crosstalk could give rise to equilibrium between the parasite and the host. The use of vector in animal models has suggested that any means by which we can control SFV cytotoxicity might be useful. Accordingly, forced evolution of vectors has allowed the generation of poorly cytolytic SFV variants, allowing long-lasting expression. Nevertheless, the direction toward which we have to push vector adaptation is complex since it depends on the desired effect. Whereas it is important to moderate cytotoxicity within producing cells, there is a need for cytotoxicity for some applications, such as cancer gene therapy. A further exciting challenge is to achieve tight, cell type-specific, replication. Currently, we are far from achieving this aim with vectors that exclusively replicate in the cytoplasm.
